World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
127
Citations
68515
World Ranking
262
National Ranking
170

Medicine

D-Index
129
Citations
70636
World Ranking
2567
National Ranking
1441

Stephen L. Hauser publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen L. Hauser sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 544 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen L. Hauser D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen L. Hauser sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 127 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1997 - Fellow of the American Academy of Arts and Sciences

Overview

Stephen L. Hauser is affiliated with the University of California, San Francisco in the United States. Their main field of study is Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Immunology, Neurology, Rheumatology, and Oncology.

The research topics covered by Stephen L. Hauser span multiple areas with an emphasis on Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, T-cell and B-cell Immunology, Polyomavirus and related diseases, Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, and Immunotherapy and Immune Responses.

Among their recent papers, the following have been published:

  • Treatment of Multiple Sclerosis: A Review, 2020, The American Journal of Medicine
  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials, 2020, JAMA Neurology
  • Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course, 2022, Cell
  • Role of B Cells in Multiple Sclerosis and Related Disorders, 2020, Annals of Neurology
  • KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19, 2022, Science

Frequent co-authors collaborating with Stephen L. Hauser include:

  • Bruce Cree
  • Ludwig Kappos
  • Jorge R. Oksenberg
  • Xavier Montalbán
  • Riley Bove

Their work is often published in established journals and venues such as:

  • Neurology
  • Multiple Sclerosis Journal
  • Annals of Neurology
  • Journal of Neurology Neurosurgery & Psychiatry
  • Multiple Sclerosis and Related Disorders

Stephen L. Hauser has been recognized as a Fellow of the American Academy of Arts and Sciences since 1997.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

    Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer

  • Risk alleles for multiple sclerosis identified by a genomewide study.

    David A. Hafler;Alastair Compston;Stephen Sawcer;Mark J. Daly

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    Walter J. Curran;Rebecca Paulus;Corey J. Langer;Ritsuko Komaki

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Identification of autoantibodies associated with myelin damage in multiple sclerosis

    Claude P. Genain;Barbara Cannella;Stephen L. Hauser;Cedric S. Raine

  • Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

    Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  • Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.

    Egle Cekanaviciute;Bryan B. Yoo;Tessel F. Runia;Justine W. Debelius

  • The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

    Stephen L. Hauser;Jorge R. Oksenberg

  • Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

    Hauser Sl;Dawson Dm;Lehrich;Beal Mf

  • Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

    Philip L De Jager;Philip L De Jager;Xiaoming Jia;Joanne Wang;Paul I W de Bakker

  • Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

    Ludwig Kappos;David Li;Peter A Calabresi;Paul O'Connor

  • Treatment of Multiple Sclerosis: A Review

    Stephen L. Hauser;Bruce A.C. Cree

  • Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis

    Simon G. Gregory;Silke Schmidt;Puneet Seth;Jorge R. Oksenberg

  • A COMPLETE GENOMIC SCREEN FOR MULTIPLE SCLEROSIS UNDERSCORES A ROLE FOR THE MAJOR HISTOCOMPATIBILITY COMPLEX

    Haines Jl;Ter-Minassian M;Bazyk A;Gusella Jf

  • INCIDENTAL MRI ANOMALIES SUGGESTIVE OF MULTIPLE SCLEROSIS: THE RADIOLOGICALLY ISOLATED SYNDROME

    Darin Okuda;E. M. Mowry;A. Beheshtian;E. Waubant

  • Ofatumumab versus Teriflunomide in Multiple Sclerosis

    Stephen L. Hauser;Amit Bar-Or;Jeffrey A. Cohen;Giancarlo Comi

  • Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

    Feng Mei;Stephen P J Fancy;Yun-An A Shen;Jianqin Niu

  • T cell gelatinases mediate basement membrane transmigration in vitro.

    D Leppert;E Waubant;R Galardy;N W Bunnett

  • Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

    Sergio E. Baranzini;Joanne Wang;Rachel A. Gibson;Nicholas Galwey

Frequent Co-Authors

Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Lisa F. Barcellos
Lisa F. Barcellos University of California, Berkeley
David A. Hafler
David A. Hafler Yale University
Bruce A. C. Cree
Bruce A. C. Cree University of California, San Francisco
S. Claiborne Johnston
S. Claiborne Johnston The University of Texas at Austin
Sergio E. Baranzini
Sergio E. Baranzini University of California, San Francisco
Margaret A. Pericak-Vance
Margaret A. Pericak-Vance University of Miami
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Howard L. Weiner
Howard L. Weiner Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare careers, including roles in nursing and specialized patient care. For those interested in entering the nursing field quickly, exploring lpn programs easy to get into can be a practical starting point. Licensed Practical Nurses provide essential support in clinical settings, often serving as a foundation for further advancement.

For students aiming to expand their qualifications, the easiest np programs to get into offer accessible routes to becoming Nurse Practitioners. These programs can be completed online, allowing for greater flexibility and balancing of work-life demands.

Specializing further in mental health, online options such as the best online pmhnp programs provide excellent clinical placement opportunities. These are vital for gaining hands-on experience in psychiatric nursing.

Cost is also a significant consideration. Prospective students may want to review cheapest pmhnp programs online to find quality education options that fit their budget while preparing them for a rewarding career in healthcare and immunology-related fields.

Best Scientists Citing Stephen L. Hauser

Trending Scientists

Recently Published Articles